Loading...
XJPX3902
Market cap110mUSD
Jan 17, Last price  
453.00JPY
1D
1.80%
1Q
-13.38%
Jan 2017
-26.34%
IPO
24.97%
Name

Medical Data Vision Co Ltd

Chart & Performance

D1W1MN
XJPX:3902 chart
P/E
17.67
P/S
2.70
EPS
25.63
Div Yield, %
1.32%
Shrs. gr., 5y
-0.93%
Rev. gr., 5y
12.40%
Revenues
6.42b
+5.15%
1,530,432,0001,950,737,0002,413,786,0002,632,390,0003,225,842,0003,577,612,0004,026,576,0004,579,731,0005,672,300,0006,104,599,0006,419,026,000
Net income
979m
+12.48%
204,925,000135,461,000164,010,000178,209,000354,599,00069,470,000554,315,000700,220,0001,087,267,000870,509,000979,125,000
CFO
1.62b
+77.46%
285,591,000206,150,000118,336,000196,378,000486,214,000120,200,0001,202,240,000964,366,0001,082,616,000910,795,0001,616,314,000
Dividend
Dec 27, 20246.5 JPY/sh

Profile

Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company also offers medical data analysis, survey, and consulting services; management consulting services for medical institutions; and medical data services, as well as plans, designs, develops, and operates portal sites. It provides its services to pharmaceutical companies, medical device manufacturer, academia, research institution, and health insurance providers. The company was founded in 2003 and is headquartered in Tokyo, Japan.
URL
https://www.mdv.co.jp/
IPO date
Dec 16, 2014
Employees
257
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,419,026
5.15%
6,104,599
7.62%
Cost of revenue
1,456,199
1,407,549
Unusual Expense (Income)
NOPBT
4,962,827
4,697,050
NOPBT Margin
77.31%
76.94%
Operating Taxes
613,624
569,516
Tax Rate
12.36%
12.12%
NOPAT
4,349,203
4,127,534
Net income
979,125
12.48%
870,509
-19.94%
Dividends
(228,827)
(217,685)
Dividend yield
0.91%
0.63%
Proceeds from repurchase of equity
3,563
(871,874)
BB yield
-0.01%
2.54%
Debt
Debt current
(755,426)
Long-term debt
Deferred revenue
Other long-term liabilities
98,629
76,607
Net debt
(3,908,248)
(3,430,203)
Cash flow
Cash from operating activities
1,616,314
910,795
CAPEX
(30,206)
(53,244)
Cash from investing activities
(437,831)
(868,752)
Cash from financing activities
(225,264)
(979,359)
FCF
4,212,111
4,129,839
Balance
Cash
3,218,073
2,264,855
Long term investments
690,175
409,922
Excess cash
3,587,297
2,369,547
Stockholders' equity
4,853,990
4,128,875
Invested Capital
828,406
462,135
ROIC
674.01%
804.10%
ROCE
112.13%
165.43%
EV
Common stock shares outstanding
38,197
38,234
Price
655.00
-27.06%
898.00
-27.93%
Market cap
25,018,935
-27.13%
34,334,374
-29.68%
EV
21,176,497
31,014,313
EBITDA
5,064,847
4,847,044
EV/EBITDA
4.18
6.40
Interest
641,709
Interest/NOPBT
13.66%